-
My Account
My Account
BSE Live
Apr 16, 16:00Prev. Close
4842.45
Open Price
4874.00
Bid Price (Qty.)
4880.00 (1)
Offer Price (Qty.)
4883.80 (1)
NSE Live
Apr 16, 15:59Prev. Close
4845.55
Open Price
4863.80
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
4893.25 (9)
| Profit & Loss account of Dr Reddys Laboratories (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| INCOME | ||||||
| Revenue From Operations [Gross] | 11,803.00 | 10,572.90 | 9,302.60 | 9,628.10 | 10,234.80 | |
| Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | 0.00 | 84.20 | |
| Revenue From Operations [Net] | 11,803.00 | 10,572.90 | 9,302.60 | 9,628.10 | 10,150.60 | |
| Total Operating Revenues | 11,850.40 | 10,625.50 | 9,359.30 | 9,719.80 | 10,207.70 | |
| Other Income | 743.20 | 238.40 | 204.00 | 591.20 | 244.80 | |
| Total Revenue | 12,593.60 | 10,863.90 | 9,563.30 | 10,311.00 | 10,452.50 | |
| EXPENSES | ||||||
| Cost Of Materials Consumed | 2,556.50 | 2,103.20 | 2,011.00 | 1,904.60 | 1,988.50 | |
| Operating And Direct Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 94.20 | |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -99.90 | 66.00 | -51.60 | 1.90 | -28.80 | |
| Employee Benefit Expenses | 2,030.20 | 1,931.90 | 1,843.00 | 1,803.30 | 1,710.00 | |
| Finance Costs | 47.80 | 56.80 | 62.80 | 57.20 | 63.80 | |
| Depreciation And Amortisation Expenses | 789.20 | 780.60 | 774.10 | 735.10 | 649.10 | |
| Other Expenses | 3,376.80 | 3,356.10 | 3,555.40 | 3,592.90 | 3,429.40 | |
| Total Expenses | 9,817.80 | 9,163.20 | 8,866.30 | 8,766.50 | 8,516.60 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 2,775.80 | 1,700.70 | 697.00 | 1,544.50 | 1,935.90 | |
| Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | -355.90 | |
| Profit/Loss Before Tax | 2,775.80 | 1,700.70 | 697.00 | 1,544.50 | 1,580.00 | |
| Tax Expenses-Continued Operations | ||||||
| Current Tax | 483.90 | 281.80 | 138.10 | 182.60 | 416.00 | |
| Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 97.00 | |
| Deferred Tax | -645.80 | 141.60 | -8.00 | -22.20 | -93.50 | |
| Tax For Earlier Years | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Tax Expenses | -161.90 | 423.40 | 130.10 | 160.40 | 225.50 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 2,937.70 | 1,277.30 | 566.90 | 1,384.10 | 1,354.50 | |
| Profit/Loss From Continuing Operations | 2,937.70 | 1,277.30 | 566.90 | 1,384.10 | 1,354.50 | |
| Profit/Loss For The Period | 2,937.70 | 1,277.30 | 566.90 | 1,384.10 | 1,354.50 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| EARNINGS PER SHARE | ||||||
| Basic EPS (Rs.) | 177.23 | 76.98 | 34.19 | 83.05 | 79.42 | |
| Diluted EPS (Rs.) | 176.88 | 76.85 | 34.12 | 82.88 | 79.14 | |
| VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 766.80 | |
| Indigenous Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 1,221.70 | |
| STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 107.00 | |
| Indigenous Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 322.10 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
| Equity Share Dividend | 391.40 | 332.00 | 399.20 | 335.30 | 340.50 | |
| Tax On Dividend | 0.00 | 68.20 | 0.00 | 0.00 | 69.30 | |
| Equity Dividend Rate (%) | 500.00 | 400.00 | 400.00 | 400.00 | 400.00 |
02.02.2021
Dr Reddys Labs Standalone December 2020 Net Sales at Rs 3,408.20 crore, up 11.96% Y-o-Y
29.01.2021
Dr Reddy's Labs Q3 profit at Rs 20 crore, revenue rises 12% YoY
29.10.2020
Dr Reddys Labs Consolidated September 2020 Net Sales at Rs 4,910.90 crore, up 2.04% Y-o-Y
29.10.2020
Dr Reddys Labs Standalone September 2020 Net Sales at Rs 3,345.80 crore, down 2.91% Y-o-Y
12.04.2021
Dr Reddy’s Lab Q4 PAT may dip 13.6% YoY to Rs. 674.5 cr: Sharekhan
29.01.2021
22.01.2021
18.01.2021
Dr. Reddy’s Laboratories Q3 PAT may dip 2% YoY to Rs. 781.6 cr: Prabhudas Lilladher
